一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-03-02,10% Owner,DUGGAN ROBERT W ,买入,96790普通股, $10.14
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-03-01,10% Owner,DUGGAN ROBERT W ,买入,410606普通股, $10.33
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-02-28,10% Owner,DUGGAN ROBERT W ,买入,20000普通股, $10.70
$Achaogen, Inc.(AKAO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-02-27 AccNo: 0001564590-18-003555 Size: 324 KB 网页链接
$Achaogen, Inc.(AKAO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-02-27 AccNo: 0001564590-18-003544 Size: 16 MB 网页链接
$Achaogen, Inc.(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2018-02-27 AccNo: 0001193125-18-061148 Size: 320 KB 网页链接
$Achaogen, Inc.(AKAO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-02-27 AccNo: 0001564590-18-003555 Size: 324 KB 网页链接
$Achaogen, Inc.(AKAO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-02-27 AccNo: 0001564590-18-003544 Size: 16 MB 网页链接
$Achaogen, Inc.(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2018-02-27 AccNo: 0001193125-18-061148 Size: 320 KB 网页链接
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2018-02-27 AccNo: 0001564590-18-003497 Size: 298 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接